Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis

Kuan-Ho Lin; Shy-Shin Chang; Chin-Wei Yu; Shen-Che Lin; Shu-Chun Liu; Hsiao-yun Chao; Meng-tse Gabriel Lee; Jiunn-Yih Wu; Chien-Chang Lee
April 2015
BMJ Open;Apr2015, Vol. 5 Issue 4, p1
Academic Journal
No abstract available.


Related Articles

  • The usefulness of brain natriuretic peptide in simple congenital heart disease – a systematic review. Eindhoven, Jannet A.; van den Bosch, Annemien E.; Boersma, Eric; Roos-Hesselink, Jolien W. // Cardiology in the Young;Jun2013, Vol. 23 Issue 3, p315 

    Brain natriuretic peptide and N-terminal pro-brain natriuretic peptide are two well-established markers for cardiac failure in acquired heart disease. Nevertheless, the clinical utility of these markers in patients with congenital heart disease remains unclear. Therefore, the aim of this study...

  • Natriuretic Peptides in Septic Patients. Piechota, M.; Barylski, M.; Hannam, S.; Mikhailidis, D. P.; Rysz, J.; Banach, M. // Current Medicinal Chemistry;Oct2009, Vol. 16 Issue 30, p4020 

    The natriuretic peptide family is comprised of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide -- DNP and urodilatin. They play a role in the diagnosis of several diseases, especially those involving the...

  • Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis. Han, Zhi-Jun; Wu, Xiao-Dan; Cheng, Juan-Juan; Zhao, Shi-Di; Gao, Ming-Zhu; Huang, Hong-Yu; Gu, Bing; Ma, Ping; Chen, Yan; Wang, Jun-Hong; Yang, Cheng-Jian; Yan, Zi-He // PLoS ONE;8/5/2015, Vol. 10 Issue 8, p1 

    Background: Previous studies have reported that natriuretic peptides in the blood and pleural fluid (PF) are effective diagnostic markers for heart failure (HF). These natriuretic peptides include N-terminal pro-brain natriuretic peptide (NT-proBNP), brain natriuretic peptide (BNP), and...

  • EVIDENCE FOR NATRIURETIC PEPTIDES A AND B AS NON-INVASIVE MARKERS IN CONGENITAL AND VALVULAR HEART DISEASE. Kotaska, Karel; Prusa, Richard // Biomedical Papers of the Medical Faculty of Palacky University i;2010, Vol. 154 Issue 1, p21 

    Aim. The aim of this study was to evaluate the diagnostic utility of natriuretic peptides of type A and B as noninvasive markers in the diagnosis and treatment of congenital and valvular heart disease. Methods. Blood samples from 82 patients with various congenital and valvular heart diseases...

  • Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates? El-Khuffash, Afif; Molloy, Eleanor J. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jul2007, Vol. 92 Issue 4, pF320 

    B-type natriuretic peptide (BNP) and N-terminal-pro-BNP (NTpBNP) have a major role in screening and diagnosis of cardiac disease and monitoring of the treatment response in children and adults. This review discusses the evidence underpinning the potential benefits of these natriuretic peptides...

  • Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence. S Dhar // Postgraduate Medical Journal;Jun2009, Vol. 85 Issue 1004, p299 

    Natriuretic peptides such as brain natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) are commonly used in the diagnosis and evaluation of heart failure. However, their utility in patients with chronic kidney disease (CKD) is less clear as renal dysfunction itself can be associated...

  • Molecular forms of natriuretic peptides in heart failure and their implications. Ye Olivia Xu-Cai; Qingyu Wu // Heart;Mar2010, Vol. 96 Issue 6, p419 

    Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are important biomarkers in the diagnosis and risk stratification for heart failure (HF). These peptides are synthesised as inactive precursors, pro-ANP and pro-BNP, which are converted to biologically active 28 amino acid ANP...

  • Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective. Dahdah, Nagib; Fournier, Anne // Diagnostics (2075-4418);Mar2013, Vol. 3 Issue 1, p1 

    Making a diagnosis of Kawasaki disease with certainty may be challenging, especially since the recognition of cases with incomplete diagnostic criteria and its consequences. In order to build the diagnostic case in daily practice, clinicians rely on clinical criteria established over four...

  • Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department. Nayer, Jamshed; Aggarwal, Praveen; Galwankar, Sagar // International Journal of Critical Illness & Injury Science;Jul-Sep2014, Vol. 4 Issue 3, p209 

    Rapid and accurate diagnosis of a patient with an acute disease is a challenge for emergency physicians. Natriuretic peptides have emerged as important tools for diagnosis, risk stratification and therapeutic decision making for some categories of emergency patients. Brain natriuretic peptide...

  • Prediction of clinical outcomes using B-type natriuretic peptides in the general population: a systematic review. Don-Wauchope, Andrew; Santaguida, Pasqualina; McKelvie, Robert; Brown, Judy; Oremus, Mark; Ali, Usman; Bustamam, Amy; Sohel, Nazmul; Hill, Stephen; Booth, Ronald; Balion, Cynthia; Raina, Parminder // Heart Failure Reviews;Aug2014, Vol. 19 Issue 4, p541 

    The use of B-type natriuretic peptides to predict outcomes in general populations has been investigated in a number of primary studies. A previous systematic review considering natriuretic peptides in cardiovascular disease included a subgroup of general population studies, which suggested an...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics